|Slideshows|October 16, 2019

7 Tips for Treating Trauma in Refugee Patients

Many refugees have been victims of severe violence that has profoundly affected their physical, psychological, and spiritual lives. Take home points here.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

ByLeah Kuntz

May 26th 2026

Childbirth-Related PTSD: Recognizing and Assessing This Unique Subtype

ByAmanda Koire, MD, PhD

May 18th 2026

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

ByJames Rachal, MD

May 16th 2026

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

ByFrank A. Clark, MD,Lindsay Hill, DNP, PMHNP

May 1st 2026

FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder

ByHeidi Anne Duerr, MPH

April 24th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

7 Tips for Treating Trauma in Refugee Patients

Related Content

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

Childbirth-Related PTSD: Recognizing and Assessing This Unique Subtype

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression

Suicide Risk Assessment in Patients Denying Suicidal Intent

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD